PATENT CLAIM ANALYSIS

Application Number: 16085714
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "383000"]

Abstract:
The present invention relates to solid oral pharmaceutical compositions comprising Deferasirox or a pharmaceutical acceptable salt thereof and one or more pharmaceutically acceptable excipients and process for preparation thereof.

Claim (Index 8):
The solid oral pharmaceutical composition according to  claim 5 , in tablet form comprising 360 mg of Deferasirox or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15185888', '13255504', '15003783', '15636174', '14087903']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.73153879623212
- 35 USC 102 Novelty (BERT): 0.5103768969616538
- Combined Prediction Score: 0.7094226063050735
- Mean Citation Score: 257.276698
- Max Citation Score: 282.34506
- Similarity Product: 198.95075667981865

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test